1. Home
  2. ARQT vs NYAX Comparison

ARQT vs NYAX Comparison

Compare ARQT & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • NYAX
  • Stock Information
  • Founded
  • ARQT 2016
  • NYAX 2005
  • Country
  • ARQT United States
  • NYAX Israel
  • Employees
  • ARQT N/A
  • NYAX N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • NYAX
  • Sector
  • ARQT Health Care
  • NYAX
  • Exchange
  • ARQT Nasdaq
  • NYAX Nasdaq
  • Market Cap
  • ARQT 2.1B
  • NYAX 1.8B
  • IPO Year
  • ARQT 2020
  • NYAX N/A
  • Fundamental
  • Price
  • ARQT $20.86
  • NYAX $46.36
  • Analyst Decision
  • ARQT Strong Buy
  • NYAX Buy
  • Analyst Count
  • ARQT 7
  • NYAX 6
  • Target Price
  • ARQT $19.00
  • NYAX $42.00
  • AVG Volume (30 Days)
  • ARQT 2.0M
  • NYAX 4.9K
  • Earning Date
  • ARQT 10-28-2025
  • NYAX 11-11-2025
  • Dividend Yield
  • ARQT N/A
  • NYAX N/A
  • EPS Growth
  • ARQT N/A
  • NYAX N/A
  • EPS
  • ARQT N/A
  • NYAX 0.57
  • Revenue
  • ARQT $263,464,999.00
  • NYAX $348,663,000.00
  • Revenue This Year
  • ARQT $72.46
  • NYAX $31.84
  • Revenue Next Year
  • ARQT $31.69
  • NYAX $22.85
  • P/E Ratio
  • ARQT N/A
  • NYAX $81.69
  • Revenue Growth
  • ARQT 99.50
  • NYAX 29.63
  • 52 Week Low
  • ARQT $8.03
  • NYAX $25.32
  • 52 Week High
  • ARQT $21.84
  • NYAX $52.46
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 59.00
  • NYAX 42.40
  • Support Level
  • ARQT $20.34
  • NYAX $46.12
  • Resistance Level
  • ARQT $21.84
  • NYAX $49.28
  • Average True Range (ATR)
  • ARQT 1.09
  • NYAX 0.74
  • MACD
  • ARQT -0.00
  • NYAX -0.22
  • Stochastic Oscillator
  • ARQT 65.37
  • NYAX 7.52

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: